Jake was last screened for CF mutations around 2002. They identified one dF508 but not his second mutation. This makes me think they missed a missense mutation?
Now that these new mutation specific drugs are coming out, we'd like Jake to get screened again. He asked his CF center about this but they were confident that his insurance claim will be denied because he already has a CF diagnosis.
Has anyone been successful in getting the full Ambry panel paid for based on the possibility of using these new drugs? Or is that just crazy talk?!
Now that these new mutation specific drugs are coming out, we'd like Jake to get screened again. He asked his CF center about this but they were confident that his insurance claim will be denied because he already has a CF diagnosis.
Has anyone been successful in getting the full Ambry panel paid for based on the possibility of using these new drugs? Or is that just crazy talk?!